Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hamishehkar, Hamed  [Clear All Filters]
2023
Dianat-Moghadam H, Abbasspour-Ravasjani S, Hamishehkar H, Rahbarghazi R, Nouri M. LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells. Med Oncol. 2023;40(6):156.
Tavassoli M, Khezerlou A, Hamishehkar H, Ehsani A, Khalilzadeh B. An ultrasensitive aptamer-based fluorescent on/off system for trace amount evaluation of Yersinia enterocolitica in food samples. Mikrochim Acta. 2023;190(7):253.
2022
Pourradi NMohammad A, Babaei H, Hamishehkar H, Baradaran B, Shokouhi-Gogani B, Shanehbandi D, Ghorbani M, Azarmi Y. Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer. Toxicol Appl Pharmacol. 2022:116036.
2021
Valizadeh A, Asghari S, Bastani S, Sarvari R, Keyhanvar N, Razin SJalilzadeh, Khiabani AYousefzade, Yousefi B, Yousefi M, Shoae-Hassani A, et al. Will stem cells from fat and growth factors from blood bring new hope to female patients with reproductive disorders?. Reprod Biol. 2021;21(2):100472.
2019
Seyfizadeh N, Seyfizadeh N, Rahbarghazi R, Nourazarian A, Borzouisileh S, Palideh A, Elahimanesh F, Hamishehkar H, Salimi L, Nouri M, et al. Isolation and characterization of human amniotic fluid and SH-SY5Y/ BE(2)-M17 cell derived exosomes. Acta Neurobiol Exp (Wars). 2019;79(3):261-269.
Hashempour S, Ghanbarzadeh S, Maibach HI, Ghorbani M, Hamishehkar H. Skin toxicity of topically applied nanoparticles. Ther Deliv. 2019.
2018
Dianat-Moghadam H, Heydarifard M, Jahanban-Esfahlan R, Panahi Y, Hamishehkar H, Pouremamali F, Rahbarghazi R, Nouri M. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems. J Control Release. 2018.
Mohammadi M, Mokarram RRezaei, Ghorbani M, Hamishehkar H. Inulinase immobilized gold-magnetic nanoparticles as a magnetically recyclable biocatalyst for facial and efficient inulin biotransformation to high fructose syrup. Int J Biol Macromol. 2018.